# Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation

> **NCT00531791** · PHASE3 · COMPLETED · sponsor: **Laval University** · enrollment: 14 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** prednisone group
- **DRUG:** Advair group

## Key facts

- **NCT ID:** NCT00531791
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531791, "Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00531791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*